No abstract available
Keywords:
CLAD-free survival; DSA de novo; HLA antibodies; IVIG; lung transplant.
MeSH terms
-
Adult
-
Female
-
Graft Rejection / immunology
-
Graft Rejection / prevention & control
-
HLA Antigens* / immunology
-
Humans
-
Immunoglobulins, Intravenous* / therapeutic use
-
Isoantibodies / immunology
-
Lung Transplantation*
-
Male
-
Middle Aged
-
Tissue Donors
Substances
-
Immunoglobulins, Intravenous
-
HLA Antigens
-
Isoantibodies
Grants and funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.